RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial.

Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial.

Add to Collection
2009 Sep RCTs Fist_Author_Year_PM

Full Author : ['Chacra, A R', 'Tan, G H', 'Apanovitch, A', 'Ravichandran, S', 'List, J', 'Chen, R']
Journal Title : International journal of clinical practice
Chapter : Section3
Journal Year : 2009
Cited by : Not Available

AIMS: Assess the efficacy and safety of saxagliptin added to a submaximal sulphonylurea dose vs. uptitration of sulphonylurea monotherapy in patients with type 2 diabetes and inadequate glycaemic control with sulphonylurea monotherapy. METHODS AND PATIENT.....

Keywords : ["sulphonylurea improve glycaemic control compare", "randomised control trial", "type diabetes", "submaximal dose", "saxagliptin add", "sulphonylurea", "uptitration", "patient"]